| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MOBQ | Common Stock | Conversion of derivative security | $1,535,032 | +7,675,160 | +1399% | $0.2000 | 8,223,695 | 06 Aug 2024 | Direct | F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MOBQ | Series H Preferred Stock | Conversion of derivative security | -751,973 | -56% | 581,544 | 06 Aug 2024 | Common Stock | 7,519,730 | $0.2000 | Direct | F1, F2, F4 |
| Id | Content |
|---|---|
| F1 | Not applicable. |
| F2 | The securities listed in Table I and II are securities owned directly by Dr. Salkind and his wife and by a family trust. |
| F3 | Includes dividend shares issued upon conversion. |
| F4 | Includes (i) 420,000 common shares underlying convertible notes, (ii) 59,211 shares underlying warrants exercisable at $60 per share, (iii) 2,333 shares underlying options exercisable at $68.48 per share and (iv) 100,000 shares underlying options exercisable at $.20 per share. |